鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/10/27 | 2,952 | 2,977 | 2,943 | 2,943 | -9 | -0.3% | 29,200 |
2021/10/26 | 2,926 | 2,964 | 2,922 | 2,952 | +26 | +0.9% | 64,900 |
2021/10/25 | 2,920 | 2,948 | 2,900 | 2,926 | -21 | -0.7% | 40,900 |
2021/10/22 | 2,932 | 2,963 | 2,926 | 2,947 | -5 | -0.2% | 43,200 |
2021/10/21 | 2,936 | 2,955 | 2,932 | 2,952 | +5 | +0.2% | 22,000 |
2021/10/20 | 2,950 | 2,968 | 2,943 | 2,947 | -14 | -0.5% | 28,700 |
2021/10/19 | 2,931 | 2,980 | 2,931 | 2,961 | +11 | +0.4% | 38,200 |
2021/10/18 | 3,035 | 3,035 | 2,946 | 2,950 | -85 | -2.8% | 40,600 |
2021/10/15 | 2,991 | 3,050 | 2,985 | 3,035 | +44 | +1.5% | 21,800 |
2021/10/14 | 2,952 | 3,005 | 2,950 | 2,991 | +35 | +1.2% | 35,800 |
2021/10/13 | 2,971 | 2,972 | 2,950 | 2,956 | -5 | -0.2% | 15,900 |
2021/10/12 | 2,971 | 2,979 | 2,946 | 2,961 | -31 | -1% | 40,700 |
2021/10/11 | 2,956 | 2,992 | 2,947 | 2,992 | +32 | +1.1% | 14,100 |
2021/10/08 | 2,985 | 2,990 | 2,952 | 2,960 | +9 | +0.3% | 25,900 |
2021/10/07 | 2,992 | 2,992 | 2,930 | 2,951 | -42 | -1.4% | 37,200 |
2021/10/06 | 2,927 | 2,999 | 2,921 | 2,993 | +111 | +3.9% | 54,400 |
2021/10/05 | 2,910 | 2,917 | 2,870 | 2,882 | -61 | -2.1% | 57,200 |
2021/10/04 | 2,901 | 2,943 | 2,901 | 2,943 | +37 | +1.3% | 34,100 |
2021/10/01 | 2,925 | 2,933 | 2,895 | 2,906 | -39 | -1.3% | 45,200 |
2021/09/30 | 2,920 | 2,969 | 2,914 | 2,945 | +10 | +0.3% | 53,400 |
2021/09/29 | 2,979 | 2,979 | 2,931 | 2,935 | -55 | -1.8% | 84,600 |
2021/09/28 | 3,015 | 3,015 | 2,963 | 2,990 | -30 | -1% | 68,100 |
2021/09/27 | 3,055 | 3,055 | 3,005 | 3,020 | -35 | -1.1% | 36,700 |
2021/09/24 | 3,075 | 3,080 | 3,025 | 3,055 | +35 | +1.2% | 36,100 |
2021/09/22 | 3,030 | 3,060 | 3,010 | 3,020 | -30 | -1% | 34,900 |
2021/09/21 | 3,030 | 3,070 | 2,985 | 3,050 | -30 | -1% | 37,400 |
2021/09/17 | 3,035 | 3,095 | 3,020 | 3,080 | +45 | +1.5% | 47,600 |
2021/09/16 | 3,010 | 3,035 | 3,000 | 3,035 | ±0 | ±0% | 54,700 |
2021/09/15 | 3,025 | 3,060 | 3,015 | 3,035 | -45 | -1.5% | 33,200 |
2021/09/14 | 3,060 | 3,085 | 3,050 | 3,080 | +15 | +0.5% | 38,200 |
2021/09/13 | 3,030 | 3,070 | 3,015 | 3,065 | +20 | +0.7% | 30,400 |
2021/09/10 | 2,981 | 3,045 | 2,974 | 3,045 | +47 | +1.6% | 52,800 |
2021/09/09 | 2,990 | 3,000 | 2,968 | 2,998 | +4 | +0.1% | 43,500 |
2021/09/08 | 2,980 | 2,999 | 2,964 | 2,994 | +14 | +0.5% | 36,900 |
2021/09/07 | 2,970 | 3,020 | 2,970 | 2,980 | +24 | +0.8% | 65,200 |
2021/09/06 | 2,949 | 2,968 | 2,928 | 2,956 | +39 | +1.3% | 36,600 |
2021/09/03 | 2,885 | 2,942 | 2,880 | 2,917 | +32 | +1.1% | 46,700 |
2021/09/02 | 2,929 | 2,933 | 2,875 | 2,885 | -57 | -1.9% | 68,700 |
2021/09/01 | 2,928 | 2,957 | 2,891 | 2,942 | +32 | +1.1% | 62,000 |
2021/08/31 | 2,900 | 2,925 | 2,889 | 2,910 | +9 | +0.3% | 42,700 |
2021/08/30 | 2,918 | 2,918 | 2,887 | 2,901 | +8 | +0.3% | 41,400 |
2021/08/27 | 2,859 | 2,893 | 2,856 | 2,893 | +35 | +1.2% | 36,000 |
2021/08/26 | 2,875 | 2,886 | 2,855 | 2,858 | -8 | -0.3% | 28,600 |
2021/08/25 | 2,866 | 2,898 | 2,827 | 2,866 | +9 | +0.3% | 45,300 |
2021/08/24 | 2,860 | 2,872 | 2,835 | 2,857 | +12 | +0.4% | 93,100 |
2021/08/23 | 2,820 | 2,861 | 2,818 | 2,845 | +44 | +1.6% | 97,200 |
2021/08/20 | 2,793 | 2,827 | 2,789 | 2,801 | +8 | +0.3% | 36,500 |
2021/08/19 | 2,709 | 2,809 | 2,701 | 2,793 | +92 | +3.4% | 112,600 |
2021/08/18 | 2,747 | 2,759 | 2,691 | 2,701 | -17 | -0.6% | 63,400 |
2021/08/17 | 2,732 | 2,750 | 2,710 | 2,718 | -6 | -0.2% | 59,300 |
851~
900
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 448,500円 | +7.1% | -35.0% | 2.68% | 37.09倍 | 1.04倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
サンバイオ | 230,700円 | - | - | 0.00% | - | 106.86倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
東和薬品 | 251,500円 | +15.0% | -7.3% | 2.78% | 8.25倍 | 0.78倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 229,300円 | +14.2% | +41.0% | 2.01% | 11.23倍 | 1.14倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 223,400円 | +21.7% | +999.9% | 0.00% | 9.30倍 | 3.08倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム